US Stock MarketDetailed Quotes
XRTX XORTX Therapeutics
- 1.2200
- -0.0450-3.56%
Close Nov 22 16:00 ET
3.93MMarket Cap10.17P/E (TTM)
1.2894High1.2000Low13.12KVolume1.2600Open1.2650Pre Close16.06KTurnover0.44%Turnover RatioLossP/E (Static)3.22MShares7.000052wk High1.84P/B3.60MFloat Cap1.090052wk Low--Dividend TTM2.95MShs Float55.0800Historical High--Div YieldTTM7.07%Amplitude1.0900Historical Low1.2230Avg Price1Lot Size
XORTX Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.78%-751.85K | 57.41%-736.54K | 47.54%-1.3M | 26.56%-6.58M | 64.08%-1.3M | -10.66%-1.07M | 7.95%-1.73M | 0.74%-2.49M | -86.70%-8.96M | -14.81%-3.61M |
| Net income from continuing operations | 55.98%-587.01K | 110.05%170.07K | -64.79%-3.02M | 72.04%-2.16M | 204.65%2.7M | -11.38%-1.33M | -36.57%-1.69M | 32.24%-1.83M | -388.76%-7.72M | -137.68%-2.58M |
| Operating gains losses | -12,285.01%-263.32K | -35,770.39%-1.64M | 12,163.50%1.73M | -11.96%-3.66M | -312.04%-3.64M | 100.27%2.16K | 99.67%-4.58K | 92.42%-14.36K | -25.17%-3.26M | 90.55%-882.99K |
| Depreciation and amortization | 57.58%25.95K | 3.21%33.05K | -51.93%32.13K | 140.25%139.69K | 7.99%24.36K | -25.34%16.47K | 228.21%32.02K | 1,670.31%66.85K | 307.58%58.15K | 469.33%22.56K |
| Other non cash items | --0 | --0 | --224.49K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -74.49%56.67K | 790.17%659.18K | 56.14%-326.87K | -169.94%-1.03M | -70.44%-412.21K | -77.35%222.17K | -122.89%-95.51K | -334.66%-745.19K | 236.03%1.47M | 68.58%-241.84K |
| -Change in receivables | 125.63%9.7K | 34.44%8.08K | -34.20%29.83K | 151.20%21.04K | 140.47%7.53K | -129.02%-37.83K | 108.73%6.01K | 153.96%45.33K | -39.87%-41.1K | 36.67%-18.61K |
| -Change in prepaid assets | 16.90%110.75K | 448.89%431.74K | -442.78%-402.07K | -77.09%142.65K | 52.92%-148.04K | -53.00%94.74K | -83.12%78.66K | -56.49%117.3K | 178.34%622.6K | 56.87%-314.46K |
| -Change in payables and accrued expense | -167.70%-111.88K | 161.53%110.85K | 105.00%45.37K | -233.87%-1.19M | -397.83%-271.7K | -74.53%165.25K | -988.26%-180.18K | -787.81%-907.82K | 444.07%892.27K | 908.34%91.23K |
| -Change in other working capital | --48.1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.78%-751.85K | 57.41%-736.54K | 47.54%-1.3M | 26.56%-6.58M | 64.08%-1.3M | -10.66%-1.07M | 7.95%-1.73M | 0.74%-2.49M | -86.70%-8.96M | -14.81%-3.61M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -217.59%-23.18K | 4.76%-9.08K | 86.71%-2.62K | -1.45%-46.36K | 41.75%-9.8K | -56.50%-7.3K | 55.81%-9.54K | -647.39%-19.73K | -43.68%-45.7K | -20.58%-16.82K |
| Net PPE purchase and sale | --0 | --0 | --0 | 78.11%-4.31K | 99.98%-1 | --0 | 88.89%-1.64K | ---2.67K | ---19.7K | ---5.42K |
| Net intangibles purchase and sale | -217.59%-23.18K | -14.97%-9.08K | 84.62%-2.62K | -61.71%-42.05K | 14.02%-9.79K | -42.50%-7.3K | -15.31%-7.9K | -546.14%-17.06K | 18.24%-26.01K | 18.32%-11.39K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -217.59%-23.18K | 4.76%-9.08K | 86.71%-2.62K | -1.45%-46.36K | 41.75%-9.8K | -56.50%-7.3K | 55.81%-9.54K | -647.39%-19.73K | -43.68%-45.7K | -20.58%-16.82K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -33.38%-22.24K | 12.66%-8.86K | 7,851.59%1.7M | -107.67%-361.04K | -106.03%-312.25K | 96.38%-16.67K | -63.72%-10.14K | -21.98K | -75.69%4.71M | -62.80%5.18M |
| Net issuance payments of debt | -33.38%-22.24K | 45.83%-8.86K | 0.73%-15.95K | -223.81%-66.09K | -755.66%-17K | -36.34%-16.67K | -163.98%-16.35K | ---16.06K | ---20.41K | ---1.99K |
| Net common stock issuance | --0 | --0 | --2M | --0 | --0 | --0 | --0 | --0 | -72.34%5M | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | 5,497.97%16.57K | 362.50%296 | --0 | --0 | --0 | --296 | -100.00%64 | -99.99%64 |
| Net other financing activities | --0 | --0 | -4,692.38%-297.61K | -9.53%-295.25K | ---- | ---- | ---- | ---6.21K | 61.41%-269.56K | 248.81%179K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -33.38%-22.24K | 12.66%-8.86K | 7,851.59%1.7M | -107.67%-361.04K | -106.03%-312.25K | 96.38%-16.67K | -63.72%-10.14K | ---21.98K | -75.69%4.71M | -62.80%5.18M |
| Net cash flow | ||||||||||
| Beginning cash position | -50.06%3.08M | -51.50%3.84M | -66.96%3.45M | -29.83%10.43M | -42.86%5.07M | -40.81%6.16M | -36.28%7.91M | -29.83%10.43M | 10,954.34%14.87M | 126.44%8.87M |
| Current changes in cash | 27.17%-797.27K | 56.86%-754.48K | 115.71%397.09K | -62.59%-6.99M | -204.79%-1.62M | 23.61%-1.09M | 8.26%-1.75M | -0.82%-2.53M | -129.57%-4.3M | -85.63%1.55M |
| Effect of exchange rate changes | 8,045.12%19.55K | -154.37%-2.49K | -903.19%-9.32K | 102.97%4.04K | -109.02%-1.45K | 99.78%-246 | 105.02%4.58K | -97.60%1.16K | -169.51%-136.15K | -91.78%16.1K |
| End cash Position | -54.61%2.3M | -50.06%3.08M | -51.50%3.84M | -66.96%3.45M | -66.96%3.45M | -42.86%5.07M | -40.81%6.16M | -36.28%7.91M | -29.83%10.43M | -29.83%10.43M |
| Free cash flow | 28.11%-775.03K | 57.12%-745.62K | 47.84%-1.31M | 26.41%-6.63M | 63.98%-1.31M | -10.88%-1.08M | 8.49%-1.74M | 0.06%-2.5M | -86.42%-9.01M | -14.83%-3.63M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data